Patents by Inventor Philippe Girard

Philippe Girard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9872858
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, to be used in the prevention or treatment of light-induced damage and/or a degeneration of the retina in a patient.
    Type: Grant
    Filed: January 28, 2015
    Date of Patent: January 23, 2018
    Assignee: BIOCODEX
    Inventors: Marc Verleye, Philippe Girard, Marie-Emmanuelle Le Guern
  • Publication number: 20170141388
    Abstract: Method for preparing an intermetallic material SnSb, said method comprising at least the following steps: a/mixing the precursors Sn and Sb, b/treating the mixture from step a/with microwaves. The intermetallic phase obtained may be used for the manufacture of electrodes.
    Type: Application
    Filed: November 16, 2016
    Publication date: May 18, 2017
    Applicants: Hutchinson, Centre National de la Recherche Scientifique, Université De Montpellier
    Inventors: David Ayme-Perrot, Philippe Sonntag, Philippe Antitomaso, Laure Monconduit, Francoise Morato-Lallemand, Philippe Girard
  • Patent number: 9611307
    Abstract: The present invention discloses novel active polypeptide fragments of human IL-33 corresponding to natural forms generated by the proteases of human neutrophils (cathepsin G, elastase 2, proteinase 3), as well as the use thereof as a drug, in particular for the treatment of infectious diseases, inflammatory diseases, atherosclerosis, cardiovascular diseases, obesity, or cancer.
    Type: Grant
    Filed: February 24, 2012
    Date of Patent: April 4, 2017
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Jean-Philippe Girard, Corinne Cayrol-Girard, Emma Lefrancais
  • Publication number: 20170000798
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, to be used in the prevention or treatment of light-induced damage and/or a degeneration of the retina in a patient.
    Type: Application
    Filed: January 28, 2015
    Publication date: January 5, 2017
    Inventors: Marc VERLEYE, Philippe GIRARD, Marie-Emmanuelle LE GUERN
  • Patent number: 9241961
    Abstract: The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: January 26, 2016
    Assignee: BIOCEDEX
    Inventors: Philippe Girard, Marie-Emmanuelle Le Guern, Marc Verleye, Bernard Hublot
  • Publication number: 20150259645
    Abstract: The present invention concerns a method of inducing IL-2-free proliferation of ?? T cells using a combination of a ?? T cell activator and IL-33 for use in therapy of infection, cancer, autoimmunity as well as other diseases.
    Type: Application
    Filed: November 8, 2013
    Publication date: September 17, 2015
    Applicants: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITÉ PAUL SABATIER TOULOUSE III
    Inventors: Mary Poupot, Jean-Jacques Fournie, Caroline Duault, Jean-Philippe Girard, Corinne Cayrol-Girard
  • Publication number: 20140099280
    Abstract: The present invention discloses novel active polypeptide fragments of human IL-33 corresponding to natural forms generated by the proteases of human neutrophils (cathepsin G, elastase 2, proteinase 3), as well as the use thereof as a drug, in particular for the treatment of infectious diseases, inflammatory diseases, atherosclerosis, cardiovascular diseases, obesity, or cancer.
    Type: Application
    Filed: February 24, 2012
    Publication date: April 10, 2014
    Applicant: Cenre National De La Recherche Scientifique
    Inventors: Jean-Philippe Girard, Corinne Cayrol-Girard, Emma Lefraancais
  • Patent number: 8598221
    Abstract: The present invention relates to a pharmaceutical composition comprising as active substances: at least one compound of the following general formula (I): and at least one inhibitor of type 2 cyclooxygenase (COX-2), notably for use in the prevention or treatment of pain.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: December 3, 2013
    Assignee: Biocodex
    Inventors: Philippe Girard, Marie-Emmanuelle Le Guern, Jean-Marie Gillardin, Bernard Hublot
  • Patent number: 8575211
    Abstract: The present invention relates to a pharmaceutical composition comprising as active substances: at least one compound of the following general formula (I): and at least one compound of the following general formula (V): especially for its use in the prevention or treatment of pain.
    Type: Grant
    Filed: October 28, 2009
    Date of Patent: November 5, 2013
    Assignee: Biocodex
    Inventors: Philippe Girard, Marie-Emmanuelle Le Guern, Laurence Berthon-Cedille, Jean-Marie Gillardin, Bernard Hublot
  • Patent number: 8420644
    Abstract: The present invention relates to the use of at least one compound of formula (I) below: or at least one of the pharmaceutically acceptable salts thereof, for the preparation of a medicament intended for the prevention or for the treatment of cerebral edemas.
    Type: Grant
    Filed: June 5, 2006
    Date of Patent: April 16, 2013
    Assignee: Biocodex
    Inventors: Marie-Emmanuelle Le Guern, Philippe Girard, Jean-Marie Gillardin, Laurence Berthon-Cedille, Bernard Hublot
  • Patent number: 8338410
    Abstract: This invention relates to the use of at least one compound of the following formula (I): or its pharmaceutically acceptable salts, for the preparation of a medicinal compound having neuroprotective activity intended to prevent or treat neurone deteriorations.
    Type: Grant
    Filed: July 18, 2006
    Date of Patent: December 25, 2012
    Assignee: Biocodex
    Inventors: Marc Verleye, Marie-Emmanuelle Le Guern, Philippe Girard, Jean-Marie Gillardin, Laurence Berthon-Cedille, Bernard Hublot
  • Publication number: 20110136885
    Abstract: The present invention relates to a pharmaceutical composition comprising as active substances: at least one compound of the following general formula (I): and at least one inhibitor of type 2 cyclooxygenase (COX-2), notably for use in the prevention or treatment of pain.
    Type: Application
    Filed: December 3, 2010
    Publication date: June 9, 2011
    Inventors: Philippe GIRARD, Marie-Emmanuelle Le Guern, Jean-Marie Gillardin, Bernard Hublot
  • Publication number: 20110135616
    Abstract: The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers.
    Type: Application
    Filed: December 7, 2010
    Publication date: June 9, 2011
    Inventors: Philippe GIRARD, Marie-Emmanuelle Le Guern, Marc Verleye, Bernard Hublot
  • Patent number: 7944280
    Abstract: A circuit for providing a bandgap voltage. The circuit includes a classic bandgap reference voltage generation circuit including first end second serially connected transistors acting as a current mirror to another portion of the classical bandgap reference circuit and being coupled between a supply voltage Vdd and an output resistor. The circuit also includes a current trimming circuit coupled in parallel with the classical bandgap reference generation circuit including a fixed element portion including a plurality of transistors and a switch portion including a plurality of switches. Each of the plurality of transistors is coupled to the supply voltage Vdd and to a one of the plurality of switches and each switch includes a fuse.
    Type: Grant
    Filed: August 26, 2008
    Date of Patent: May 17, 2011
    Assignee: International Business Machines Corporation
    Inventors: Bertrand Gabillard, Philippe Girard, Michel Rivier
  • Patent number: 7892727
    Abstract: Described herein are chemokine-binding domains of THAP-family polypeptides and pharmaceutical compositions which include a polypeptide comprising a chemokine-binding domain of a THAP-family polypeptide. Also disclosed are methods of binding chemokines, inhibiting the activity of chemokines, detecting chemokines, and reducing the symptoms associated with a chemokine mediated or influenced condition by contacting the chemokine with an agent that includes a polypeptide comprising a chemokine binding domain of a THAP-family polypeptide.
    Type: Grant
    Filed: May 3, 2006
    Date of Patent: February 22, 2011
    Assignee: Centre National de la Recherche Scientifique CNRS
    Inventors: Jean-Philippe Girard, Myriam Roussigne, Francois Amalric
  • Patent number: 7858297
    Abstract: Described herein are chemokine-binding domains of THAP-family polypeptides and pharmaceutical compositions which include a polypeptide comprising a chemokine-binding domain of a THAP-family polypeptide. Also disclosed are methods of binding chemokines, inhibiting the activity of chemokines, detecting chemokines, and reducing the symptoms associated with a chemokine mediated or influenced condition by contacting the chemokine with an agent that includes a polypeptide comprising a chemokine binding domain of a THAP-family polypeptide.
    Type: Grant
    Filed: June 19, 2003
    Date of Patent: December 28, 2010
    Assignee: Centre National de la Recherche Scientifique CNRS
    Inventors: Jean-Philippe Girard, Myriam Roussigne, Francois Amalric
  • Publication number: 20100317592
    Abstract: Described herein are chemokine-binding domains of THAP-family polypeptides and pharmaceutical compositions which include a polypeptide comprising a chemokine-binding domain of a THAP-family polypeptide. Also disclosed are methods of binding chemokines, inhibiting the activity of chemokines, detecting chemokines, and reducing the symptoms associated with a chemokine mediated or influenced condition by contacting the chemokine with an agent that includes a polypeptide comprising a chemokine binding domain of a THAP-family polypeptide.
    Type: Application
    Filed: June 25, 2010
    Publication date: December 16, 2010
    Inventors: Jean-Philippe Girard, Myriam Roussigne, Francois Amalric
  • Publication number: 20100197777
    Abstract: The present invention relates to a pharmaceutical composition comprising as active substances: at least one compound of the following general formula (I): and at least one compound of the following general formula (V): especially for its use in the prevention or treatment of pain.
    Type: Application
    Filed: October 28, 2009
    Publication date: August 5, 2010
    Inventors: Philippe GIRARD, Marie-Emmanuelle Le Guern, Laurence Berthon-Cedille, Jean-Marie Gillardin, Bernard Hublot
  • Publication number: 20100021482
    Abstract: The invention relates to genes and proteins of the THAP (THanatos (death)-Associated Protein) family comprising a THAP domain, and their use in diagnostics, treatment of disease, and in the identification of molecules for the treatment of disease. The invention also relates to the Par4 protein and SLC chemokine pathways, including the interaction of Par4 and SLC with THAP family proteins, and the recruitment and localization of Par4 to PML nuclear bodies.
    Type: Application
    Filed: June 11, 2009
    Publication date: January 28, 2010
    Inventors: Jean-Philippe Girard, Francois Amalric, Myriam Roussigne, Thomas Clouaire
  • Publication number: 20090289697
    Abstract: A circuit for providing a bandgap voltage. The circuit includes a classic bandgap reference voltage generation circuit including first end second serially connected transistors acting as a current mirror to another portion of the classical bandgap reference circuit and being coupled between a supply voltage Vdd and an output resistor. The circuit also includes a current trimming circuit coupled in parallel with the classical bandgap reference generation circuit including a fixed element portion including a plurality of transistors and a switch portion including a plurality of switches. Each of the plurality of transistors is coupled to the supply voltage Vdd and to a one of the plurality of switches and each switch includes a fuse.
    Type: Application
    Filed: August 26, 2008
    Publication date: November 26, 2009
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Bertrand Gabillard, Philippe Girard, Michel Rivier